United Therapeutics reported $88.2M in Stock for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amarin AMRN:US $ 267.82M 33.14M
Baxter International BAX:US $ 2548M 95M
Bayer BAYN:GR € 10869M 445M
Biocryst Pharmaceuticals BCRX:US $ 16.14M 0.35M
Biogen BIIB:US $ 1215.4M 136.1M
Biomarin Pharmaceutical BMRN:US $ 786.36M 9.69M
Emergent Biosolutions EBS:US $ 400.7M 49.9M
Esperion Therapeutics ESPR:US $ 35.65M 1.26M
Gilead Sciences GILD:US $ 2675M 1057M
GlaxoSmithKline GSK:LN 6003M 220M
Halozyme Therapeutics HALO:US $ 47.76M 6.15M
Intra Cellular Therapies ITCI:US $ 7.89M 0.06M
Johnson & Johnson JNJ:US $ 10990M 603M
Moderna Inc MRNA:US 1.94B 501M
Pfizer PFE:US $ 9979M 920M
Ptc Therapeutics PTCT:US $ 15.28M 0.57M
Regeneron Pharmaceuticals REGN:US $ 1991.5M 488.7M
Sarepta Therapeutics SRPT:US $ 199M 12.78M
Seattle Genetics SGEN:US $ 275.75M 75.08M
Teva Pharmaceutical TEVA:IT 4.01B 194M
United Therapeutics UTHR:US $ 88.2M 5.6M
Vertex Pharmaceuticals VRTX:US $ 338.9M 14.2M